Cargando…
Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories
Plant in vitro cultures represent an attractive and cost-effective alternative to classical approaches to plant secondary metabolite (PSM) production (the “Plant Cell Factory” concept). Among other advantages, they constitute the only sustainable and eco-friendly system to obtain complex chemical st...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273650/ https://www.ncbi.nlm.nih.gov/pubmed/26848649 http://dx.doi.org/10.3390/molecules21020182 |
_version_ | 1783377436166062080 |
---|---|
author | Ramirez-Estrada, Karla Vidal-Limon, Heriberto Hidalgo, Diego Moyano, Elisabeth Golenioswki, Marta Cusidó, Rosa M. Palazon, Javier |
author_facet | Ramirez-Estrada, Karla Vidal-Limon, Heriberto Hidalgo, Diego Moyano, Elisabeth Golenioswki, Marta Cusidó, Rosa M. Palazon, Javier |
author_sort | Ramirez-Estrada, Karla |
collection | PubMed |
description | Plant in vitro cultures represent an attractive and cost-effective alternative to classical approaches to plant secondary metabolite (PSM) production (the “Plant Cell Factory” concept). Among other advantages, they constitute the only sustainable and eco-friendly system to obtain complex chemical structures biosynthesized by rare or endangered plant species that resist domestication. For successful results, the biotechnological production of PSM requires an optimized system, for which elicitation has proved one of the most effective strategies. In plant cell cultures, an elicitor can be defined as a compound introduced in small concentrations to a living system to promote the biosynthesis of the target metabolite. Traditionally, elicitors have been classified in two types, abiotic or biotic, according to their chemical nature and exogenous or endogenous origin, and notably include yeast extract, methyl jasmonate, salicylic acid, vanadyl sulphate and chitosan. In this review, we summarize the enhancing effects of elicitors on the production of high-added value plant compounds such as taxanes, ginsenosides, aryltetralin lignans and other types of polyphenols, focusing particularly on the use of a new generation of elicitors such as coronatine and cyclodextrins. |
format | Online Article Text |
id | pubmed-6273650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62736502018-12-28 Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories Ramirez-Estrada, Karla Vidal-Limon, Heriberto Hidalgo, Diego Moyano, Elisabeth Golenioswki, Marta Cusidó, Rosa M. Palazon, Javier Molecules Review Plant in vitro cultures represent an attractive and cost-effective alternative to classical approaches to plant secondary metabolite (PSM) production (the “Plant Cell Factory” concept). Among other advantages, they constitute the only sustainable and eco-friendly system to obtain complex chemical structures biosynthesized by rare or endangered plant species that resist domestication. For successful results, the biotechnological production of PSM requires an optimized system, for which elicitation has proved one of the most effective strategies. In plant cell cultures, an elicitor can be defined as a compound introduced in small concentrations to a living system to promote the biosynthesis of the target metabolite. Traditionally, elicitors have been classified in two types, abiotic or biotic, according to their chemical nature and exogenous or endogenous origin, and notably include yeast extract, methyl jasmonate, salicylic acid, vanadyl sulphate and chitosan. In this review, we summarize the enhancing effects of elicitors on the production of high-added value plant compounds such as taxanes, ginsenosides, aryltetralin lignans and other types of polyphenols, focusing particularly on the use of a new generation of elicitors such as coronatine and cyclodextrins. MDPI 2016-02-03 /pmc/articles/PMC6273650/ /pubmed/26848649 http://dx.doi.org/10.3390/molecules21020182 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ramirez-Estrada, Karla Vidal-Limon, Heriberto Hidalgo, Diego Moyano, Elisabeth Golenioswki, Marta Cusidó, Rosa M. Palazon, Javier Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories |
title | Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories |
title_full | Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories |
title_fullStr | Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories |
title_full_unstemmed | Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories |
title_short | Elicitation, an Effective Strategy for the Biotechnological Production of Bioactive High-Added Value Compounds in Plant Cell Factories |
title_sort | elicitation, an effective strategy for the biotechnological production of bioactive high-added value compounds in plant cell factories |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273650/ https://www.ncbi.nlm.nih.gov/pubmed/26848649 http://dx.doi.org/10.3390/molecules21020182 |
work_keys_str_mv | AT ramirezestradakarla elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories AT vidallimonheriberto elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories AT hidalgodiego elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories AT moyanoelisabeth elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories AT golenioswkimarta elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories AT cusidorosam elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories AT palazonjavier elicitationaneffectivestrategyforthebiotechnologicalproductionofbioactivehighaddedvaluecompoundsinplantcellfactories |